Mohlatlego Sebola
Dados Biográficos
| ID | 257122 |
|---|---|
| NOME | Mohlatlego Sebola |
| PRENOMES | Mohlatlego |
| SOBRENOME | Sebola |
| ASSINATURA | SEBOLA M |
| AFILIAÇÕES | Health Professions Council of South Africa (HPCSA) |
| VERIFICADO | Não |
| TOTAL DE OBRAS | 2 |
| TOTAL DE CITAÇÕES | 3 |
| TOTAL COMO AUTOR | 2 |
| TOTAL COMO EDITOR | 0 |
| PRIMEIRO ANO DE PUBLICAÇÃO | 2004 |
| ANO MAIS RECENTE DE PUBLICAÇÃO | 2005 |
| ÍNDICE H | 1 |
Phase III microbicide trial methodology
In preparation for effectiveness trials of candidate vaginal microbicides, scientists are debating trial design and implementation challenges, including choice of control arm(s), product-sharing across arms, and visit schedules. This study involved a survey of South African women participating in an expanded safety trial of the candidate microbicide Carraguard gel. The first 100 consenting women who attended the study clinics in Ga-Rankuwa and Gu…
Microbicide trials for preventing HIV/Aids in South Africa
The Microbicide Division of the Department of Medical Microbiology at MEDUNSA, South Africa, recently completed a phase II expanded safety trial of the candidate microbicide Carraguard. A microbicide is a vaginal product that women might use, if proven safe and effective, to protect themselves from HIV and possibly other sexually transmitted infections (STIs). The study participants were from Ga-Rankuwa and its neighbouring areas, an historically…
Microbicide trials for preventing HIV/Aids in South Africa
The Microbicide Division of the Department of Medical Microbiology at MEDUNSA, South Africa, recently completed a phase II expanded safety trial of the candidate microbicide Carraguard. A microbicide is a vaginal product that women might use, if proven safe and effective, to protect themselves from HIV and possibly other sexually transmitted infections (STIs). The study participants were from Ga-Rankuwa and its neighbouring areas, an historically…
Microbicide trials for preventing HIV/Aids in South Africa
The Microbicide Division of the Department of Medical Microbiology at MEDUNSA, South Africa, recently completed a phase II expanded safety trial of the candidate microbicide Carraguard. A microbicide is a vaginal product that women might use, if proven safe and effective, to protect themselves from HIV and possibly other sexually transmitted infections (STIs). The study participants were from Ga-Rankuwa and its neighbouring areas, an historically…
Phase III microbicide trial methodology
In preparation for effectiveness trials of candidate vaginal microbicides, scientists are debating trial design and implementation challenges, including choice of control arm(s), product-sharing across arms, and visit schedules. This study involved a survey of South African women participating in an expanded safety trial of the candidate microbicide Carraguard gel. The first 100 consenting women who attended the study clinics in Ga-Rankuwa and Gu…
Adolescent Sexual and Reproductive Health (2 obras) · Environmental health (2 obras) · Family medicine (2 obras) · HIV/AIDS Research and Interventions (2 obras) · Medicine (2 obras) · Microbicide (2 obras) · Microbicides for sexually transmitted diseases (2 obras) · Population (2 obras) · Condom (1 obras) · Focus group (1 obras)